XML 24 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income (loss) $ 6,460 $ (23,118) $ (51,952)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation 523 434 377
Gain on sale of property and equipment (246)
Amortization of debt financing costs 916 262 40
Impairment of inventory 2,843 3,170 3,002
Stock-based compensation 3,079 1,363 1,268
Change in fair value of warrant liabilities (2,464)
Changes in operating assets and liabilities:      
Accounts receivable (3,845) 937 (1,075)
Inventory (949,591) 169,079 (60,731)
Prepaid expenses and other assets (5,288) 115 (937)
Accounts payable 4,130 841 (2,421)
Accrued and other liabilities 21,563 1,781 3,455
Net cash (used in) provided by operating activities (921,920) 154,864 (108,974)
Cash flows from investing activities:      
Purchases of property and equipment (13,687) (2,858) (1,039)
Proceeds from sales of property and equipment 2,032 60
Net cash used in investing activities (11,655) (2,858) (979)
Cash flows from financing activities:      
Proceeds from Business Combination 284,011
Issuance cost of common stock (51,249)
Borrowings from credit facilities and notes payable 2,764,071 799,997 1,077,781
Repayments of credit facilities and notes payable (1,912,837) (960,510) (1,019,347)
Payment of debt financing costs (7,632) (457) (52)
Proceeds from exercise of stock options 902 170
Proceeds from issuance of Class C preferred stock, net 29,823 74,601
Repurchase of common stock (10,650)
Net cash provided by (used in) financing activities 1,077,266 (131,147) 122,503
Net change in cash, cash equivalents and restricted cash 143,691 20,859 12,550
Cash, cash equivalents and restricted cash, beginning of period 50,742 29,883 17,333
Cash, cash equivalents and restricted cash, end of period 194,433 50,742 29,883
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet:      
Cash and cash equivalents 169,817 43,938 22,856
Restricted cash 24,616 6,804 7,027
Supplemental disclosure of cash flow information:      
Cash payments for interest 21,875 14,048 20,008
Supplemental disclosure of non-cash investing and financing activities:      
Transfer of property and equipment, net to inventory 14,464 0 0
Acquisition of warrant liabilities 26,525 0 0
Conversion of preferred stock to common stock 184,123 0 0
Conversion of treasury stock 184,123 0 0
Treasury Stock      
Supplemental disclosure of non-cash investing and financing activities:      
Conversion of preferred stock to common stock 10,650 0 0
Conversion of treasury stock $ 10,650 $ 0 $ 0